Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") said today that normalized Funds From Operations ("FFO") for the quarter ended June 30, 2013 increased seven percent to $298.4 million, from $277.8 million for the comparable 2012 period. Normalized FFO per diluted common share was $1.01 for the quarter ended June 30, 2013, a six percent increase from $0.95 for the comparable 2012 period. Weighted average diluted shares outstanding for the quarter rose by one percent to 295.1 million, compared to 292.6 million in the second quarter of 2012.

"We are pleased to deliver another quarter of excellent results and consistent, superior performance," Ventas Chairman and Chief Executive Officer Debra A. Cafaro said. "With market-leading growth from our high-quality seniors housing operating portfolio, our total same-store cash flow growth was three percent, we successfully renewed or transitioned all 89 healthcare assets whose leases expired during the quarter, and we began to deploy the attractive capital we sourced earlier in the year in accretive investments," she added. "We are increasing our full-year outlook, reflecting the strength of our business model and execution."

The growth in second quarter 2013 normalized FFO per diluted common share compared to the second quarter of 2012 is due primarily to the Company's $2.7 billion of investments in 2012; net operating income increases in its high-quality private pay seniors housing communities managed by Atria Senior Living, Inc. ("Atria") and Sunrise Senior Living, LLC ("Sunrise"), its triple-net lease portfolio and its medical office building ("MOB") segment; and lower weighted average interest rates. These benefits were partially offset by higher debt balances; increases in net cash balances during the quarter resulting from capital raises, asset sales and receipt of loan repayments; and an increase in weighted average diluted shares outstanding.

Normalized FFO for the quarter ended June 30, 2013 excludes the net benefit (totaling $6.1 million, or $0.02 per diluted share) from an income tax benefit and net gains on debt extinguishment, offset by merger-related expenses and deal costs (including integration costs) and amortization of other intangibles. Normalized FFO for the quarter ended June 30, 2012 excluded the net expense (totaling $41.8 million, or $0.14 per diluted share) from merger-related expenses and deal costs (including integration costs), loss on extinguishment of debt, and amortization of other intangibles, offset by an income tax benefit.

Normalized FFO for the six months ended June 30, 2013 increased 11 percent to $599.9 million, from $541.7 million for the comparable 2012 period. Normalized FFO per diluted common share was $2.04 for the six months ended June 30, 2013, a ten percent increase from $1.86 for the comparable 2012 period. Normalized FFO for the six months ended June 30, 2013 excludes the net expense (totaling $0.2 million, or $0.00 per diluted share) from merger-related expenses and deal costs (including integration costs) and amortization of other intangibles, offset by an income tax benefit and gains on debt extinguishment. Normalized FFO for the six months ended June 30, 2012 excluded the net expense (totaling $90.9 million, or $0.31 per diluted share) from merger-related expenses and deal costs (including integration costs), loss on extinguishment of debt, non-cash income tax expense and amortization of other intangibles.

Net income attributable to common stockholders for the quarter ended June 30, 2013 was $114.6 million, or $0.39 per diluted common share, including discontinued operations of $(18.1) million. Net income attributable to common stockholders for the quarter ended June 30, 2012 was $74.0 million, or $0.25 per diluted common share, including discontinued operations of $31.3 million. This $40.6 million increase in net income attributable to common stockholders in the second quarter of 2013 over the prior year comparable period is primarily the result of the increases described above for normalized FFO, changes in losses on extinguishment of debt, decreases in merger-related expenses and deal costs (including integration costs) and income tax benefit increases, partially offset by year-over-year changes in discontinued operations.

Net income attributable to common stockholders for the six months ended June 30, 2013 was $226.8 million, or $0.77 per diluted common share, including discontinued operations of $(23.9) million. Net income attributable to common stockholders for the six months ended June 30, 2012 was $164.7 million, or $0.56 per diluted common share, including discontinued operations of $74.6 million. This $62.1 million increase in net income attributable to common stockholders for the six months ended June 30, 2013 over the prior year six-month period is primarily the result of the increases described above for normalized FFO, changes in losses on extinguishment of debt, decreases in merger-related expenses and deal costs (including integration costs) and income tax benefit increases, partially offset by year-over-year changes in discontinued operations and additional depreciation and amortization.

FFO, as defined by the National Association of Real Estate Investment Trusts ("NAREIT"), for the quarter ended June 30, 2013 increased 29 percent to $304.4 million, from $236.0 million in the comparable 2012 period. NAREIT FFO per diluted common share for the quarter ended June 30, 2013 increased 27 percent to $1.03, from $0.81 in the second quarter of 2012.

NAREIT FFO for the six months ended June 30, 2013 increased 33 percent to $599.7 million, from $450.8 million in the comparable 2012 period. NAREIT FFO per diluted common share for the six months ended June 30, 2013 increased 32 percent to $2.04, from $1.55 in the six months ended June 30, 2012.

PRIVATE PAY SENIORS HOUSING OPERATING PORTFOLIO

Second Quarter 2013 Same-Store NOI Grows 6.9 Percent Year over Year and Occupancy Rises 160 Basis Points

At June 30, 2013, the Company's seniors housing operating portfolio included 227 communities, seven of which were acquired in the second quarter of 2013: 132 seniors housing communities managed by Atria and 95 seniors housing communities managed by Sunrise. Second quarter 2013 Net Operating Income ("NOI") after management fees for this portfolio totaled $110.1 million.

For the 196 private pay seniors housing communities owned by the Company for the full second quarters of 2013 and 2012 ("same-store"), average unit occupancy rose 160 basis points to 90.8 percent, NOI after management fees grew 6.9 percent and REVPOR (revenue per occupied room) grew 3.7 percent in the second quarter of 2013 compared to the second quarter of 2012.

SECOND QUARTER HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

Investments and Dispositions

  • Since April 1, 2013, Ventas invested $419 million in private pay seniors housing communities, MOBs and other assets. Atria became the operator of seven of these seniors housing communities at the time of closing. The expected first-year unlevered yield on these investments approximates 6.5 percent. $96 million of these investments occurred following quarter end.
  • Since April 1, 2013, Ventas sold assets (including loans) and received final repayments on outstanding loans and investments totaling $160 million. Over $70 million of this activity occurred following quarter end.
  • The Company has approximately $400 million of additional investments under contract. However, there can be no assurances as to whether or, if so, when these transactions will close.

Liquidity, Capital Raising and Balance Sheet

  • Under its previously established "at-the-market" equity offering program ("ATM"), the Company received aggregate proceeds of approximately $77.4 million from sales of its common stock during the second quarter and none in the third quarter to date.
  • The Company's debt to total capitalization at June 30, 2013 was approximately 29 percent. The Company's net debt to Adjusted Pro Forma EBITDA (as defined herein) at June 30, 2013 was 5.3x.
  • At June 30, 2013, the Company had $260 million of borrowings outstanding under its unsecured revolving credit facility and $62 million of cash and cash equivalents. Currently, it has $300 million in borrowings outstanding under its unsecured revolving credit facility and approximately $56 million of cash and cash equivalents.

PORTFOLIO UPDATE AND ADDITIONAL INFORMATION

  • The Company owned 1,283 properties for the full second quarters of 2013 and 2012 ("same-store"). Cash NOI growth for the Company's total same-store portfolio was approximately three percent in the second quarter of 2013 compared to the second quarter of 2012.
  • As previously announced, Ventas entered into lease renewals, new leases or sale contracts for all 89 licensed healthcare facilities leased by Kindred Healthcare, Inc. (NYSE: KND) ("Kindred") whose lease term was up for renewal May 1, 2013. All transactions and operating transitions were completed on or before July 1, 2013.
  • The 143 skilled nursing facilities ("SNFs") and long-term acute care hospitals ("LTACs") currently master leased by the Company to Kindred produced EBITDARM (earnings before interest, taxes, depreciation, amortization, rent and management fees) to actual cash rent coverage of 2.0x for the trailing 12-month period ended March 31, 2013 (the latest date available).
  • Supplemental information regarding the Company can be found on the Company's website under the "Investor Relations" section or at www.ventasreit.com/investor-relations/financial-information/supplemental-information.

VENTAS RAISES 2013 NORMALIZED FFO PER DILUTED SHARE GUIDANCE TO $4.06 TO $4.10

Ventas currently expects its 2013 normalized FFO per diluted share to range between $4.06 and $4.10, improving its previously announced 2013 guidance of between $3.99 and $4.07 per diluted share. The Company has included the impact of approximately $400 million of additional acquisitions in its updated guidance. For the full year, Ventas expects average fully diluted shares outstanding to be approximately 295 million.

The Company continues to expect that 2013 NOI from the Atria- and Sunrise-managed seniors housing communities that were included in its original full-year NOI guidance will be $430 million to $440 million. If achieved, this would represent five to eight percent same-store NOI growth.

Excluding non-cash items from normalized FFO (projected to be $0.12 per diluted share), computed consistent with prior periods, the midpoint of the Company's improved guidance range constitutes approximately ten percent per share growth in 2013. A reconciliation of the Company's guidance, and the non-cash items, to the Company's projected GAAP earnings is included elsewhere in this press release.

The Company's normalized FFO guidance (and related GAAP earnings projections) for all periods assumes, with certain immaterial exceptions, that all of the Company's tenants and borrowers continue to meet all of their obligations to the Company. In addition, the Company's normalized FFO guidance excludes, other than as specifically stated, (a) net gains on the sales of real property assets, including gain on re-measurement of equity method investments, (b) merger-related costs and expenses, including amortization of intangibles and transition and integration expenses, and deal costs and expenses, (c) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company's debt, (d) the non-cash effect of income tax benefits or expenses and derivative transactions that have non-cash mark-to-market impacts on the Company's income statement, and (e) the impact of future unannounced acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions.

The Company's guidance is based on a number of other assumptions that are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurances that the Company will achieve these results. The Company may from time to time update its publicly announced guidance, but it is not obligated to do so.

SECOND QUARTER CONFERENCE CALL

Ventas will hold a conference call to discuss this earnings release today at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (857) 244-7319. The participant passcode is "Ventas." The conference call is being webcast live by Thomson Reuters and can be accessed at the Company's website at www.ventasreit.com or at www.earnings.com. A replay of the webcast will be available today online, or by calling (617) 801-6888, passcode 58823878, beginning at approximately 12:00 p.m. Eastern Time and will be archived for 28 days.

Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of more than 1,400 assets in 47 states (including the District of Columbia) and two Canadian provinces consists of seniors housing communities, skilled nursing facilities, hospitals, medical office buildings and other properties. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company's or its tenants', operators', borrowers' or managers' expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, merger integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust ("REIT"), plans and objectives of management for future operations and statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will" and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from the Company's expectations. The Company does not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

The Company's actual future results and trends may differ materially from expectations depending on a variety of factors discussed in the Company's filings with the Securities and Exchange Commission. These factors include without limitation: (a) the ability and willingness of the Company's tenants, operators, borrowers, managers and other third parties to satisfy their obligations under their respective contractual arrangements with the Company, including, in some cases, their obligations to indemnify, defend and hold harmless the Company from and against various claims, litigation and liabilities; (b) the ability of the Company's tenants, operators, borrowers and managers to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities and other indebtedness; (c) the Company's success in implementing its business strategy and the Company's ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions and investments, including investments in different asset types and outside the United States; (d) macroeconomic conditions such as a disruption of or lack of access to the capital markets, changes in the debt rating on U.S. government securities, default or delay in payment by the United States of its obligations, and changes in the federal budget resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; (e) the nature and extent of future competition; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company's borrowing costs as a result of changes in interest rates and other factors; (h) the ability of the Company's operators and managers, as applicable, to comply with laws, rules and regulations in the operation of the Company's properties, to deliver high-quality services, to attract and retain qualified personnel and to attract residents and patients; (i) changes in general economic conditions or economic conditions in the markets in which the Company may, from time to time, compete, and the effect of those changes on the Company's revenues, earnings and funding sources; (j) the Company's ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; (k) the Company's ability and willingness to maintain its qualification as a REIT in light of economic, market, legal, tax and other considerations; (l) final determination of the Company's taxable net income for the year ended December 31, 2012 and for the year ending December 31, 2013; (m) the ability and willingness of the Company's tenants to renew their leases with the Company upon expiration of the leases, the Company's ability to reposition its properties on the same or better terms in the event of nonrenewal or in the event the Company exercises its right to replace an existing tenant, and obligations, including indemnification obligations, the Company may incur in connection with the replacement of an existing tenant; (n) risks associated with the Company's senior living operating portfolio, such as factors that can cause volatility in the Company's operating income and earnings generated by those properties, including without limitation national and regional economic conditions, costs of food, materials, energy, labor and services, employee benefit costs, insurance costs and professional and general liability claims, and the timely delivery of accurate property-level financial results for those properties; (o) changes in U.S. and Canadian currency exchange rates; (p) year-over-year changes in the Consumer Price Index and the effect of those changes on the rent escalators contained in the Company's leases, including the rent escalators for two of the Company's master lease agreements with Kindred, and the Company's earnings; (q) the Company's ability and the ability of its tenants, operators, borrowers and managers to obtain and maintain adequate property, liability and other insurance from reputable, financially stable providers; (r) the impact of increased operating costs and uninsured professional liability claims on the Company's liquidity, financial condition and results of operations or that of the Company's tenants, operators, borrowers and managers, and the ability of the Company and the Company's tenants, operators, borrowers and managers to accurately estimate the magnitude of those claims; (s) risks associated with the Company's MOB portfolio and operations, including the Company's ability to successfully design, develop and manage MOBs, to accurately estimate its costs in fixed fee-for-service projects and to retain key personnel; (t) the ability of the hospitals on or near whose campuses the Company's MOBs are located and their affiliated health systems to remain competitive and financially viable and to attract physicians and physician groups; (u) the Company's ability to build, maintain and expand its relationships with existing and prospective hospital and health system clients; (v) risks associated with the Company's investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners' financial condition; (w) the impact of market or issuer events on the liquidity or value of the Company's investments in marketable securities; (x) merger and acquisition activity in the healthcare industry resulting in a change of control of one or more of the Company's tenants, operators, borrowers or managers or significant changes in the senior management of the Company's tenants, operators, borrowers or managers; and (y) the impact of litigation or any financial, accounting, legal or regulatory issues that may affect the Company or its tenants, operators, borrowers or managers. Many of these factors are beyond the control of the Company and its management.

 
CONSOLIDATED BALANCE SHEETS
As of June 30, 2013, March 31, 2013, December 31, 2012, September 30, 2012 and June 30, 2012
(In thousands, except per share amounts)
         
June 30, March 31, December 31, September 30, June 30,
2013 2013 2012 2012 2012
 
Assets
Real estate investments:
Land and improvements $ 1,783,664 $ 1,764,208 $ 1,772,417 $ 1,754,826 $ 1,744,752
Buildings and improvements 17,238,843 16,977,860 16,920,821 16,552,534 16,181,392
Construction in progress 99,947 72,714 70,665 93,992 133,890
Acquired lease intangibles 990,548   984,023   981,704   965,500   920,116  
20,113,002 19,798,805 19,745,607 19,366,852 18,980,150
Accumulated depreciation and amortization (2,977,154 ) (2,803,068 ) (2,634,075 ) (2,447,175 ) (2,256,197 )
Net real estate property 17,135,848 16,995,737 17,111,532 16,919,677 16,723,953
Secured loans receivable and investments, net 470,441 490,107 635,002 215,775 213,193
Investments in unconsolidated entities 93,155   94,257   95,409   90,992   104,636  
Net real estate investments 17,699,444 17,580,101 17,841,943 17,226,444 17,041,782
Cash and cash equivalents 62,421 57,690 67,908 58,530 52,803
Escrow deposits and restricted cash 94,492 99,225 105,913 76,908 114,883
Deferred financing costs, net 50,821 54,079 42,551 25,426 25,750
Other assets 889,404   915,826   921,685   1,053,591   987,043  
Total assets $ 18,796,582   $ 18,706,921   $ 18,980,000   $ 18,440,899   $ 18,222,261  
 
Liabilities and equity
Liabilities:
Senior notes payable and other debt $ 8,420,073 $ 8,295,908 $ 8,413,646 $ 7,494,774 $ 7,204,727
Accrued interest 50,860 58,086 47,565 56,326 47,842
Accounts payable and other liabilities 887,314 910,692 995,156 1,049,043 1,059,385
Deferred income taxes 247,591   261,122   259,715   265,116   271,066  
Total liabilities 9,605,838 9,525,808 9,716,082 8,865,259 8,583,020
 
Redeemable OP unitholder and noncontrolling interests 184,217 194,302 174,555 113,908 116,635
 
Commitments and contingencies
 
Equity:
Ventas stockholders' equity:

Preferred stock, $1.00 par value; 10,000 shares authorized, unissued

-- -- -- -- --

Common stock, $0.25 par value; 296,940, 295,823, 295,565, 295,534 and 295,370 shares issued at June 30, 2013, March 31, 2013, December 31, 2012, September 30, 2012 and June 30, 2012, respectively

74,248 73,969 73,904 73,896 73,855
Capital in excess of par value 9,996,095 9,904,694 9,920,962 9,941,030 9,932,839
Accumulated other comprehensive income 19,752 21,828 23,354 23,626 21,404
Retained earnings (deficit) (943,384 ) (861,434 ) (777,927 ) (680,888 ) (609,487 )

Treasury stock, 3,698, 3,736, 3,699, 0 and 0 shares at June 30, 2013, March 31, 2013, December 31, 2012, September 30, 2012 and June 30, 2012, respectively

(221,129 ) (223,709 ) (221,165 ) --   --  
Total Ventas stockholders' equity 8,925,582 8,915,348 9,019,128 9,357,664 9,418,611
Noncontrolling interest 80,945   71,463   70,235   104,068   103,995  
Total equity 9,006,527   8,986,811   9,089,363   9,461,732   9,522,606  
Total liabilities and equity $ 18,796,582   $ 18,706,921   $ 18,980,000   $ 18,440,899   $ 18,222,261  
 

CONSOLIDATED STATEMENTS OF INCOME
For the three and six months ended June 30, 2013 and 2012
(In thousands, except per share amounts)
       
For the Three Months For the Six Months
Ended June 30, Ended June 30,
 
2013 2012 2013 2012
Revenues:
Rental income:
Triple-net leased $ 214,239 $ 204,561 $ 427,760 $ 407,798
Medical office buildings 110,946   89,110   222,092   153,075  
325,185 293,671 649,852 560,873
Resident fees and services 341,594 303,437 680,764 588,630
Medical office building and other services revenue 3,537 6,639 7,185 12,247
Income from loans and investments 14,733 8,152 30,836 16,188
Interest and other income 797   65   1,835   112  
Total revenues 685,846 611,964 1,370,472 1,178,050
 
Expenses:
Interest 83,046 72,767 162,452 140,678
Depreciation and amortization 172,706 187,367 351,495 347,563
Property-level operating expenses:
Senior living 231,337 207,031 462,245 402,165
Medical office buildings 38,401   29,621   74,942   50,324  
269,738 236,652 537,187 452,489
Medical office building services costs 1,667 3,839 3,306 6,827
General, administrative and professional fees 27,327 26,423 56,101 48,621
(Gain) loss on extinguishment of debt, net (720 ) 9,989 (720 ) 39,533
Merger-related expenses and deal costs 6,667 36,668 10,929 44,649
Other 4,385   1,510   8,972   3,086  
Total expenses 564,816   575,215   1,129,722   1,083,446  

 

Income before income from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest

121,030 36,749 240,750 94,604
(Loss) income from unconsolidated entities (506 ) 514 423 831
Income tax benefit (expense) 12,064   5,179   10,320   (6,159 )
Income from continuing operations 132,588 42,442 251,493 89,276
Discontinued operations (18,055 ) 31,294   (23,862 ) 74,552  
Net income 114,533 73,736 227,631 163,828
Net (loss) income attributable to noncontrolling interest (47 ) (289 ) 858   (823 )
Net income attributable to common stockholders $ 114,580   $ 74,025   $ 226,773   $ 164,651  
 
Earnings per common share:
Basic:

Income from continuing operations attributable to common stockholders

$ 0.45 $ 0.15 $ 0.86 $ 0.31
Discontinued operations (0.06 ) 0.11   (0.08 ) 0.26  
Net income attributable to common stockholders $ 0.39   $ 0.26   $ 0.78   $ 0.57  
Diluted:

Income from continuing operations attributable to common stockholders

$ 0.45 $ 0.14 $ 0.85 $ 0.30
Discontinued operations (0.06 ) 0.11   (0.08 ) 0.26  
Net income attributable to common stockholders $ 0.39   $ 0.25   $ 0.77   $ 0.56  
 
Weighted average shares used in computing earnings per common share:
Basic 292,635 290,170 292,049 289,281
Diluted 295,123 292,592 294,584 291,711
 
Dividends declared per common share $ 0.67 $ 0.62 $ 1.34 $ 1.24
 

QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
         
2013 Quarters 2012 Quarters
Second First Fourth Third Second
 
Revenues:
Rental income:
Triple-net leased $ 214,239 $ 213,521 $ 207,570 $ 207,975 $ 204,561
Medical office buildings 110,946   111,146   108,951   100,814   89,110  
325,185 324,667 316,521 308,789 293,671
Resident fees and services 341,594 339,170 321,933 316,560 303,437
Medical office building and other services revenue 3,537 3,648 3,950 4,544 6,639
Income from loans and investments 14,733 16,103 14,690 9,035 8,152
Interest and other income 797   1,038   665   330   65  
Total revenues 685,846 684,626 657,759 639,258 611,964
 
Expenses:
Interest 83,046 79,406 76,166 74,357 72,767
Depreciation and amortization 172,706 178,789 182,668 189,052 187,367
Property-level operating expenses:
Senior living 231,337 230,908 222,551 216,306 207,031
Medical office buildings 38,401   36,541   39,684   36,144   29,621  
269,738 267,449 262,235 252,450 236,652
Medical office building services costs 1,667 1,639 1,569 1,487 3,839
General, administrative and professional fees 27,327 28,774 23,022 26,867 26,423
(Gain) loss on extinguishment of debt, net (720 ) -- (699 ) (1,194 ) 9,989
Merger-related expenses and deal costs 6,667 4,262 13,617 4,917 36,668
Other 4,385   4,587   1,887   1,966   1,510  
Total expenses 564,816   564,906   560,465   549,902   575,215  
 

 

Income before income from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest

121,030 119,720 97,294 89,356 36,749
(Loss) income from unconsolidated entities (506 ) 929 249 17,074 514
Income tax benefit (expense) 12,064   (1,744 ) 3,555   8,886   5,179  
Income from continuing operations 132,588 118,905 101,098 115,316 42,442
Discontinued operations (18,055 ) (5,807 ) (14,972 ) (3,495 ) 31,294  
Net income 114,533 113,098 86,126 111,821 73,736
Net (loss) income attributable to noncontrolling interest (47 ) 905   (141 ) (61 ) (289 )
Net income attributable to common stockholders $ 114,580   $ 112,193   $ 86,267   $ 111,882   $ 74,025  
 
Earnings per common share:
Basic:

Income from continuing operations attributable to common stockholders

$ 0.45 $ 0.40 $ 0.34 $ 0.39 $ 0.15
Discontinued operations (0.06 ) (0.02 ) (0.05 ) (0.01 ) 0.11  
Net income attributable to common stockholders $ 0.39   $ 0.38   $ 0.29   $ 0.38   $ 0.26  
Diluted:

Income from continuing operations attributable to common stockholders

$ 0.45 $ 0.40 $ 0.34 $ 0.39 $ 0.14
Discontinued operations (0.06 ) (0.02 ) (0.05 ) (0.01 ) 0.11  
Net income attributable to common stockholders $ 0.39   $ 0.38   $ 0.29   $ 0.38   $ 0.25  
 

Weighted average shares used in computing earnings per common share:

Basic 292,635 291,455 294,704 294,928 290,170
Diluted 295,123 293,924 297,089 297,407 292,592
 

CONSOLIDATED STATEMENTS OF CASH FLOWS
For the six months ended June 30, 2013 and 2012
(In thousands)
  2013   2012
Cash flows from operating activities:
Net income $ 227,631 $ 163,828
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amounts in discontinued operations) 380,932 366,405
Amortization of deferred revenue and lease intangibles, net (7,003 ) (8,829 )
Other non-cash amortization (9,401 ) (21,185 )
Stock-based compensation 10,800 11,086
Straight-lining of rental income, net (14,330 ) (10,470 )
(Gain) loss on extinguishment of debt, net (873 ) 39,533
Gain on real estate dispositions, net (including amounts in discontinued operations) (2,195 ) (78,791 )
Gain on real estate loan investments (1,099 ) 559
Gain on sale of marketable securities (856 ) --
Income tax (benefit) expense (including amounts in discontinued operations) (10,320 ) 6,138
Loss (income) from unconsolidated entities 818 (831 )
Gain on re-measurement of equity interest upon acquisition, net (1,241 ) --
Other 3,872 5,990
Changes in operating assets and liabilities:
(Increase) decrease in other assets (16,415 ) 861
Increase in accrued interest 3,315 10,259
Decrease in accounts payable and other liabilities (55,947 ) (23,745 )
Net cash provided by operating activities 507,688 460,808
Cash flows from investing activities:
Net investment in real estate property (283,622 ) (899,404 )
Purchase of noncontrolling interest (6,124 ) (3,934 )
Investment in loans receivable and other (32,332 ) (27,260 )
Proceeds from real estate disposals 24,290 8,847
Proceeds from loans receivable 218,043 33,223
Proceeds from sale or maturity of marketable securities 5,493 --
Funds held in escrow for future development expenditures 11,816 --
Development project expenditures (48,284 ) (60,561 )
Capital expenditures (32,459 ) (23,812 )
Other (411 ) (2,150 )
Net cash used in investing activities (143,590 ) (975,051 )
Cash flows from financing activities:
Net change in borrowings under revolving credit facility (280,926 ) (88,654 )
Proceeds from debt 918,455 1,269,315
Repayment of debt (685,518 ) (645,722 )
Payment of deferred financing costs (12,997 ) (2,980 )
Issuance of common stock, net 82,384 342,469
Cash distribution to common stockholders (392,230 ) (361,957 )
Cash distribution to redeemable OP unitholders (2,313 ) (2,241 )
Purchases of redeemable OP units (208 ) (611 )
Contributions from noncontrolling interest 2,094 --
Distributions to noncontrolling interest (5,045 ) (2,907 )
Other 6,808   14,509  
Net cash (used in) provided by financing activities (369,496 ) 521,221  
Net (decrease) increase in cash and cash equivalents (5,398 ) 6,978
Effect of foreign currency translation on cash and cash equivalents (89 ) 18
Cash and cash equivalents at beginning of period 67,908   45,807  
Cash and cash equivalents at end of period $ 62,421   $ 52,803  
 
Supplemental schedule of non-cash activities:
Assets and liabilities assumed from acquisitions:
Real estate investments $ 90,020 $ 364,883
Utilization of funds held for an Internal Revenue Code Section 1031 exchange -- (134,003 )
Other assets acquired 2,562 81,509
Debt assumed 68,602 250,363
Other liabilities 10,493 26,639
Deferred income tax liability 1,794 5,895
Noncontrolling interests 11,693 25,166
Equity issued -- 4,326
Debt transferred on the sale of assets -- 14,535
 

QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
         
2013 Quarters 2012 Quarters
Second First Fourth Third Second
Cash flows from operating activities:
Net income $ 114,533 $ 113,098 $ 86,126 $ 111,821 $ 73,736
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amounts in discontinued operations) 193,989 186,943 201,748 196,622 201,769
Amortization of deferred revenue and lease intangibles, net (3,693 ) (3,310 ) (4,153 ) (4,136 ) (3,669 )
Other non-cash amortization (4,072 ) (5,329 ) (8,617 ) (10,141 ) (11,077 )
Stock-based compensation 5,138 5,662 4,255 5,443 6,252
Straight-lining of rental income, net (6,465 ) (7,865 ) (7,330 ) (6,242 ) (5,580 )
(Gain) loss on extinguishment of debt, net (873 ) -- (699 ) (1,194 ) 9,989
Gain on real estate dispositions, net (including amounts in discontinued operations) (1,718 ) (477 ) (1,804 ) (357 ) (38,558 )
Gain on real estate loan investments (759 ) (340 ) (5,789 ) -- --
Gain on sale of marketable securities (856 ) -- -- -- --
Income tax (benefit) expense (including amounts in discontinued operations) (12,064 ) 1,744 (3,555 ) (8,869 ) (5,167 )
Loss (income) from unconsolidated entities 506 312 (249 ) (429 ) (514 )
Gain on re-measurement of equity interest upon acquisition, net -- (1,241 ) -- (16,645 ) --
Other 967 2,905 3,942 482 2,908
Changes in operating assets and liabilities:
(Increase) decrease in other assets (5,956 ) (10,459 ) 15,686 (12,791 ) (414 )
(Decrease) increase in accrued interest (7,215 ) 10,530 (8,761 ) 8,471 (10,193 )
Increase (decrease) in accounts payable and other liabilities 5,921   (61,868 ) 12,697   (13,524 ) (3,635 )
Net cash provided by operating activities 277,383 230,305 283,497 248,511 215,847
Cash flows from investing activities:
Net investment in real estate property (227,447 ) (56,175 ) (298,153 ) (255,508 ) (898,904 )
Purchase of private investment funds -- -- (276,419 ) -- --
Purchase of noncontrolling interest (2,938 ) (3,186 ) -- -- (3,934 )
Investment in loans receivable and other (29,543 ) (2,789 ) (422,035 ) (3,263 ) (4,787 )
Proceeds from real estate disposals 13,040 11,250 73,900 66,298 --
Proceeds from loans receivable 71,649 146,394 8,402 1,594 15,979
Proceeds from sale or maturity of marketable securities 5,493 -- 37,500 -- --
Funds held in escrow for future development expenditures 6,376 5,440 (28,050 ) -- --
Development project expenditures (26,696 ) (21,588 ) (23,883 ) (29,558 ) (29,287 )
Capital expenditures (12,664 ) (19,795 ) (27,160 ) (18,458 ) (13,793 )
Other (333 ) (78 ) 115   40   (13 )
Net cash (used in) provided by investing activities (203,063 ) 59,473 (955,783 ) (238,855 ) (934,739 )
Cash flows from financing activities:
Net change in borrowings under revolving credit facility 94,990 (375,916 ) (163,983 ) 337,575 293,744
Proceeds from debt 1,584 916,871 1,142,023 299,067 601,985
Repayment of debt (49,725 ) (635,793 ) (90,023 ) (457,278 ) (346,921 )
Payment of deferred financing costs 811 (13,808 ) (19,513 ) (1,277 ) (1,187 )
Issuance of common stock, net 77,334 5,050 -- -- 342,469
Cash distribution to common stockholders (196,530 ) (195,700 ) (183,306 ) (183,283 ) (182,704 )
Cash distribution to redeemable OP unitholders (1,162 ) (1,151 ) (1,088 ) (1,117 ) (1,129 )
Purchases of redeemable OP units (100 ) (108 ) (2,841 ) (1,149 ) (378 )
Contributions from noncontrolling interest 2,094 -- -- -- --
Distributions to noncontrolling interest (3,595 ) (1,450 ) (1,180 ) (1,128 ) (1,315 )
Other 4,750   2,058   1,573   4,621   13,944  
Net cash (used in) provided by financing activities (69,549 ) (299,947 ) 681,662   (3,969 ) 718,508  
Net increase (decrease) in cash and cash equivalents 4,771 (10,169 ) 9,376 5,687 (384 )
Effect of foreign currency translation on cash and cash equivalents (40 ) (49 ) 2 40 (37 )
Cash and cash equivalents at beginning of period 57,690   67,908   58,530   52,803   53,224  
Cash and cash equivalents at end of period $ 62,421   $ 57,690   $ 67,908   $ 58,530   $ 52,803  
 
Supplemental schedule of non-cash activities:
Assets and liabilities assumed from acquisitions:
Real estate investments $ 81,181 $ 8,839 $ 84,939 $ 132,872 $ 310,002
Utilization of funds held for an Internal Revenue Code Section 1031 exchange -- -- -- -- (96,204 )
Other assets acquired 1,894 668 (22,159 ) 18,380 86,635
Debt assumed 68,602 -- 44,923 117,539 232,629
Other liabilities 4,071 6,422 9,707 34,045 33,628
Deferred income tax liability 262 1,532 -- (1,596 ) 5,895
Noncontrolling interests 10,140 1,553 8,150 1,264 28,281
Equity issued -- -- -- -- --
Debt transferred on the sale of assets -- -- -- -- --
 

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Funds From Operations (FFO) Including and Excluding Non-Cash Items1

(Dollars in thousands, except per share amounts)
 
              Tentative Estimates  
Preliminary and
Subject to Change YOY
2012       2013 FY2013 - Guidance Growth (2)
Q2   Q3   Q4   FY   Q1   Q2   Low   High   '12-'13E
Net income attributable to common stockholders $ 74,025 $ 111,882 $ 86,267 $ 362,800 $ 112,193 $ 114,580 $

455,729

  $

495,029

Net income attributable to common stockholders per share $ 0.25 $ 0.38 $ 0.29 $ 1.23 $ 0.38$0.39$

1.54

$

1.68

 
Adjustments:
Depreciation and amortization on real estate assets 186,366 187,800 181,400 714,860 177,511 171,290 699,679 689,679

Depreciation on real estate assets related to noncontrolling interest

(2,336 ) (2,221 ) (2,435 ) (8,503 ) (2,502 ) (2,617 ) (9,373 ) (11,373 )

Depreciation on real estate assets related to unconsolidated entities

2,131 1,700 1,510 7,516 1,646 1,622 7,035 6,035

Gain on re-measurement of equity interest upon acquisition, net

-- (16,645 ) -- (16,645 ) (1,241 ) -- (1,241 ) (1,241 )
Discontinued operations:
(Gain) loss on real estate dispositions, net (38,558 ) (357 ) (1,804 ) (80,952 ) (477 ) (1,718 )

(195

)

(4,195

)
Depreciation and amortization on real estate assets 14,402     7,570     19,079     45,491     8,154     21,284    

32,000

   

30,000

 
Subtotal: funds from operations add-backs 162,005 177,847 197,750 661,767 183,091 189,861

727,905

708,905

Subtotal: funds from operations add-backs per share   $ 0.55     $ 0.60     $ 0.67     $ 2.25     $ 0.62     $0.64     $2.47     $2.40      
Funds From Operations $ 236,030 $ 289,729 $ 284,017 $ 1,024,567 $ 295,284 $ 304,441 $

1,183,634

$

1,203,934

17

%
Funds From Operations per share   $ 0.81     $ 0.97     $ 0.96     $ 3.48     $ 1.00     $1.03     $

4.01

    $

4.08

    16%
 
Adjustments:
Merger-related expenses and deal costs 36,668 4,917 13,617 63,183 4,262 6,592

15,000

20,000

Income tax expense (benefit) (5,166 ) (8,870 ) (3,555 )

(6,286

) 1,744 (12,064 )

(7,500

)

(10,000

)
Loss (gain) on extinguishment of debt 9,989 (1,194 ) (699 ) 37,640 -- (873 ) 5,000 (5,000 )
Change in fair value of financial instruments 60 58 (52 ) 99 25 -- 25 25
Amortization of other intangibles 255     256     255     1,022     256     255     1,522     522  
Subtotal: normalized funds from operations add-backs 41,806 (4,833 ) 9,566

95,658

6,287 (6,090 )

14,047

5,547

 

Subtotal: normalized funds from operations add-backs per share   $ 0.14     $ (0.02 )   $ 0.03     $ 0.32     $ 0.02     $ (0.02 )   $

0.05

    $

0.02

 

   
Normalized Funds From Operations $ 277,836 $ 284,896 $ 293,583 $

1,120,225

$ 301,571 $ 298,351 $ 1,197,681 $ 1,209,481 7 %
Normalized Funds From Operations per share   $ 0.95     $ 0.96     $ 0.99     $ 3.80     $ 1.03     $1.01     $4.06     $4.10     7%
 
Non-cash items included in normalized FFO:
Amortization of deferred revenue and
lease intangibles, net (3,669 ) (4,136 ) (4,153 ) (17,118 ) (3,310 ) (3,693 ) (14,386 ) (14,386 )

Other non-cash amortization, including fair market value of debt

(11,077 ) (10,141 ) (8,617 ) (39,943 ) (5,329 ) (4,072 )

(16,169

)

(17,169

)
Stock-based compensation 6,252 5,443 4,255 20,784 5,662 5,138

20,457

21,457

Straight-lining of rental income, net (5,580 )   (6,242 )   (7,330 )   (24,042 )   (7,865 )   (6,465 )   (26,034 )  

(26,534

)
Subtotal: non-cash items included in normalized FFO (14,074 ) (15,076 ) (15,845 ) (60,319 ) (10,842 ) (9,092 ) (36,132 )

(36,632

)
Subtotal: normalized funds from operations add-backs per share   $ (0.05 )   $ (0.05 )   $ (0.05 )   $ (0.20 )   $ (0.04 )   $ (0.03 )   $ (0.12 )   $ (0.12 )    
Normalized FFO, excluding non-cash items $ 263,762 $ 269,820 $ 277,738 $

1,059,906

$ 290,729 $ 289,259 $ 1,161,549 $

1,172,849

10 %
Normalized FFO, excluding non-cash items per share   $ 0.90     $ 0.91     $ 0.93     $

3.60

    $ 0.99     $0.98     $3.94     $3.98     10%
Weighted average diluted shares 292,592 297,407 297,089 294,488 293,924 295,123 294,995     294,995  
 

1 Totals and per share amounts may not add due to rounding. Per share quarterly amounts may not add to annual per share amounts due to material changes in the Company's weighted average diluted share count, if any.

2 2012-2013E growth assumes the midpoint of 2013 guidance.
 

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen or fallen with market conditions, many industry investors have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. To overcome this problem, the Company considers FFO and normalized FFO appropriate measures of operating performance of an equity REIT. Moreover, the Company believes that normalized FFO provides useful information because it allows investors, analysts and Company management to compare the Company's operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items such as transactions and litigation.

The Company uses the NAREIT definition of FFO. NAREIT defines FFO as net income, computed in accordance with GAAP, excluding gains (or losses) from sales of real estate property, including gain on re-measurement of equity method investments, and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. The Company defines normalized FFO as FFO excluding the following income and expense items (which may be recurring in nature): (a) net gains on the sales of real property assets, including gain on re-measurement of equity method investments; (b) merger-related costs and expenses, including amortization of intangibles and transition and integration expenses, and deal costs and expenses, including expenses and recoveries relating to acquisition lawsuits; (c) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company's debt; (d) the non-cash effect of income tax benefits or expenses and derivative transactions that have non-cash mark-to-market impacts on the Company's income statement; (e) except as specifically stated in the case of guidance, the impact of future acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions; (f) the financial impact of contingent consideration; (g) charitable donations made to the Ventas Charitable Foundation; and (h) gains and losses for non-operational foreign currency hedge agreements and changes in the fair value of financial instruments.

FFO and normalized FFO presented herein may not be identical to FFO and normalized FFO presented by other real estate companies due to the fact that not all real estate companies use the same definitions. FFO and normalized FFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are FFO and normalized FFO necessarily indicative of sufficient cash flow to fund all of the Company's needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO and normalized FFO should be examined in conjunction with net income as presented elsewhere herein.

NON-GAAP FINANCIAL MEASURES RECONCILIATION
Net Debt to Adjusted Pro Forma EBITDA

The following information considers the pro forma effect on net income, interest and depreciation of the Company's investments and other capital transactions that were completed during the three months ended June 30, 2013, as if the transactions had been consummated as of the beginning of the period. The following table illustrates net debt to pro forma earnings before interest, taxes, depreciation and amortization (including non-cash stock-based compensation expense), excluding gains or losses on extinguishment of debt, merger-related expenses and deal costs, net gains on real estate activity and changes in the fair value of financial instruments (including amounts in discontinued operations) ("Adjusted Pro Forma EBITDA") (dollars in thousands):

Net income attributable to common stockholders   $ 114,580
Pro forma adjustments for current period investments, capital
transactions and dispositions 4,808  
Pro forma net income for the three months ended June 30, 2013 119,388
Add back:
Pro forma interest (including discontinued operations) 85,388
Pro forma depreciation and amortization (including discontinued operations) 194,124
Stock-based compensation 5,138
Gain on real estate dispositions, net (1,718 )
Gain on extinguishment of debt, net (873 )
Income tax benefit (12,064 )
Other taxes 1,197
Merger-related expenses and deal costs 4,431  
Adjusted Pro Forma EBITDA $ 395,011  
Adjusted Pro Forma EBITDA annualized $ 1,580,044  
 
 
As of June 30, 2013:
Debt $ 8,420,073
Cash, including cash escrows pertaining to debt (95,345 )
Net debt $ 8,324,728  
 
Net debt to Adjusted Pro Forma EBITDA 5.3   x
 

Non-GAAP Financial Measures Reconciliation
(In thousands, except per share amounts)
   
For the Six Months
Ended June 30,
2013 2012
 
Net income attributable to common stockholders $ 226,773 $ 164,651
Adjustments:
Depreciation and amortization on real estate assets 348,801 345,660
Depreciation on real estate assets related to noncontrolling interest (5,119 ) (3,847 )
Depreciation on real estate assets related to unconsolidated entities 3,268 4,306

Gain on re-measurement of equity interest upon acquisition, net

(1,241 ) --
Discontinued operations:
Gain on real estate dispositions, net (2,195 ) (78,791 )
Depreciation and amortization on real estate assets 29,438   18,842  
FFO 599,725 450,821
Merger-related expenses and deal costs 10,854 44,649

Income tax (benefit) expense

(10,320 )

6,139

(Gain) loss on extinguishment of debt, net (873 ) 39,533
Change in fair value of financial instruments 25 93
Amortization of other intangibles 511   511  
Normalized FFO $ 599,922   $ 541,746  
 
Per diluted share (1):
Net income attributable to common stockholders $ 0.77 $ 0.56
Adjustments:
Depreciation and amortization on real estate assets 1.18 1.18
Depreciation on real estate assets related to noncontrolling interest (0.02 ) (0.01 )
Depreciation on real estate assets related to unconsolidated entities 0.01 0.01
Gain on re-measurement of equity interest upon acquisition, net 0.00 --
Discontinued operations:
Gain on real estate dispositions, net (0.01 ) (0.27 )
Depreciation and amortization on real estate assets 0.10   0.06  
FFO 2.04 1.55
Merger-related expenses and deal costs 0.04 0.15

Income tax (benefit) expense

(0.04 ) 0.02

(Gain) loss on extinguishment of debt, net

0.00 0.14
Change in fair value of financial instruments 0.00 0.00
Amortization of other intangibles 0.00   0.00  
Normalized FFO $ 2.04   $ 1.86  
 
(1) Per share amounts may not add due to rounding.
 

NON-GAAP FINANCIAL MEASURES RECONCILIATION
NOI by Segment
(In thousands)
     
2013 Quarters 2012 Quarters
Second First Fourth   Third   Second
Revenues
 
Triple-Net
Triple-Net Rental Income $ 214,239 $ 213,521 $ 207,570 $ 207,975 $ 204,561
 
Medical Office Buildings
Medical Office - Stabilized 102,083 102,450 100,027 92,458 80,336
Medical Office - Lease up 8,863   8,696   8,924   8,356   8,774
Total Medical Office Buildings - Rental Income 110,946   111,146   108,951   100,814   89,110
Total Rental Income 325,185 324,667 316,521 308,789 293,671
 
Medical Office Building Services Revenue 2,159   2,537   2,840   3,434   5,529
Total Medical Office Buildings - Revenue 113,105 113,683 111,791 104,248 94,639
 
Triple-Net Services Revenue 1,115 1,111 1,110 1,110 1,110
Non-Segment Services Revenue 263   --   --   --   --
Total Medical Office Building and Other Services Revenue 3,537 3,648 3,950 4,544 6,639
 
Seniors Housing Operating
Seniors Housing - Stabilized 336,754 334,536 317,608 312,241 299,345
Seniors Housing - Lease up 4,114 3,892 3,582 3,579 3,360
Seniors Housing - Other 726   742   743   740   732
Total Resident Fees and Services 341,594 339,170 321,933 316,560 303,437
 
Non-Segment Income from Loans and Investments 14,733   16,103   14,690   9,035   8,152
Total Revenues, excluding Interest and Other Income 685,049 683,588 657,094 638,928 611,899
 
Property-Level Operating Expenses
 
Medical Office Buildings
Medical Office - Stabilized 35,232 33,723 36,360 32,981 26,401
Medical Office - Lease up 3,169   2,818   3,324   3,163   3,220
Total Medical Office Buildings 38,401 36,541 39,684 36,144 29,621
 
Seniors Housing Operating
Seniors Housing - Stabilized 227,907 227,456 218,857 212,933 203,770
Seniors Housing - Lease up 2,814 2,839 3,114 2,743 2,657
Seniors Housing - Other 616   613   580   630   604
Total Seniors Housing 231,337   230,908   222,551   216,306   207,031
Total Property-Level Operating Expenses 269,738 267,449 262,235 252,450 236,652
 
Medical Office Building Services Costs 1,667 1,639 1,569 1,487 3,839
 
Net Operating Income
 
Triple-Net
Triple-Net Properties 214,239 213,521 207,570 207,975 204,561
Triple-Net Services Revenue 1,115   1,111   1,110   1,110   1,110
Total Triple-Net 215,354 214,632 208,680 209,085 205,671
 
Medical Office Buildings
Medical Office - Stabilized 66,851 68,727 63,667 59,477 53,935
Medical Office - Lease up 5,694 5,878 5,600 5,193 5,554
Medical Office Buildings Services 492   898   1,271   1,947   1,690
Total Medical Office Buildings 73,037 75,503 70,538 66,617 61,179
 
Seniors Housing Operating
Seniors Housing - Stabilized 108,847 107,080 98,751 99,308 95,575
Seniors Housing - Lease up 1,300 1,053 468 836 703
Seniors Housing - Other 110   129   163   110   128
Total Seniors Housing 110,257 108,262 99,382 100,254 96,406
Non-Segment 14,996   16,103   14,690   9,035   8,152
Net Operating Income $ 413,644   $ 414,500   $ 393,290   $ 384,991   $ 371,408
 
Note: Amounts above are adjusted to exclude discontinued operations for all periods presented.
 

NON-GAAP FINANCIAL MEASURES RECONCILIATION
Total Same-Store Portfolio NOI
(Dollars in thousands)
 
For the Three Months Ended
June 30,
2013   2012
 
Net Operating Income $ 413,644 $ 371,408
 
Less:
NOI Not Included in Same-Store 32,048 7,251
Straight-Lining of Rental Income 6,465 5,476
Non-Cash Rental Income 2,829 3,441
Non-Segment NOI 14,996   8,153  
56,338   24,321  
 
Same-Store Cash NOI $ 357,306   $ 347,087  
 
Percentage Increase 3 %
 

Click here to subscribe to Mobile Alerts for Ventas, Inc.

Ventas, Inc.
Lori B. Wittman, (877) 4-VENTAS